Nathanael Fillmore, PhD
Assistant Professr
Boston University Chobanian & Avedisian School of Medicine
Medicine
Hematology & Medical Oncology

PhD, University of Wisconsin Madison
MS, University of Wisconsin Madison
BA, Carleton College



Dr. Fillmore leads a group at the VA Boston Healthcare System and Harvard Medical School that uses VA clinical, genomic, and imaging data, together with machine learning and statistical methods, in research to improve patient care. They are also working on software and methodological improvements to support these efforts.


Cancer-Associated Thromboembolism as Affected by Health Disparities (CAT-HD)
07/01/2021 - 06/30/2025 (PI of Sub-Project / SP)
PI: Katya Ravid, DSc
American Heart Association




Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Ferri GM, Yildirim C, Do NV, Brophy MT, Munshi NC, Edwards CV, Fillmore NR. Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple Myeloma. EJHaem. 2025 Dec; 6(6):e70153.View Related Profiles. PMID: 41278511
     
  2. Li A, Jafari O, Lam BD, Jiang JY, Kim RB, Ma S, Zhou E, Tiong JW, Chiang EC, Ryu J, Amos CI, La J, Fillmore NR. Validation of a Risk Score for Cancer-Associated Thrombosis Using Nationwide EHR Data. JAMA Netw Open. 2025 Nov 03; 8(11):e2544428.View Related Profiles. PMID: 41288979
     
  3. Lotfollahzadeh S, Jose A, Yang X, Bathla T, Lazowski A, Hoekstra I, Sethuraman K, Potluri S, Dulberger KN, La J, Fillmore NR, Piqueras MDC, Lee N, Cabral H, Ravid K, Chitalia VC. Dietary tryptophan augments cancer-associated venous thrombogenicity mitigated by indoleamine 2,3-dioxygenase 1 inhibition. Blood Adv. 2025 Oct 14; 9(19):4910-4923.View Related Profiles. PMID: 40668615; PMCID: PMC12508897; DOI: 10.1182/bloodadvances.2025017079;
     
  4. Zheng C, Khan A, Ritter D, Marks DS, Do NV, Fillmore NR, Sander C. Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication records. Cell Rep Med. 2025 Sep 16; 6(9):102359.View Related Profiles. PMID: 40961920; PMCID: PMC12490214; DOI: 10.1016/j.xcrm.2025.102359;
     
  5. La J, Hshieh T, Hamparsumian A, Zwolinski R, Wood J, Dharne M, Gaziano JM, Brophy MT, Do NV, Munshi NC, Driver JA, Abel GA, Fillmore NR, DuMontier C. Potentially Inappropriate Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care System. J Natl Compr Canc Netw. 2025 Sep; 23(9):363-370.View Related Profiles. PMID: 40930142; PMCID: PMC12742238; DOI: 10.6004/jnccn.2025.7051;
     
  6. Agar A, Shah V, Hyma Kunhiraman H, Nahle T, Madabhushi A, Riaz IB, Bandaru M, Okwuosa TM, Fillmore N, Guha A. Transforming Cardio-Oncology Care Through AI-Driven Large Language Model Systems: A Roadmap for Future Implementation. JACC Adv. 2025 Oct; 4(10 Pt 2):102117. PMID: 40884990; PMCID: PMC12417552; DOI: 10.1016/j.jacadv.2025.102117;
     
  7. Culnan JM, Goryachev SD, Bihn JR, Lee G, Chen DCR, Soloviev O, Zwolinski R, Dulberger KN, Do NV, Paller CJ, Cooperberg MR, Fillmore NR. Automated Extraction of Imaging and Pathology Data From Diverse Prostate Cancer Electronic Records. JCO Clin Cancer Inform. 2025 Aug; 9:e2500085.View Related Profiles. PMID: 40773714; PMCID: PMC12352557; DOI: 10.1200/CCI-25-00085;
     
  8. Jafari O, Ma S, Lam BD, Jiang JY, Zhou E, Ranjan M, Ryu J, Bandyo R, Maghsoudi A, Peng B, Amos CI, Oluyomi A, Fillmore NR, La J, Li A. Development and validation of venous thromboembolism-bidirectional encoder representations from transformers (VTE-BERT) natural language processing model. J Thromb Haemost. 2025 Aug 05.View Related Profiles. PMID: 40754035; PMCID: PMC12360494; DOI: 10.1016/j.jtha.2025.07.021;
     
  9. Kim DY, Huhmann L, Hippe DS, Wheless L, Pavlis M, Hwang JC, Brophy MT, Do NV, Nghiem P, Fillmore N, Hartman RI. Treatment and disease-specific survival differences among veterans with Merkel cell carcinoma. J Am Acad Dermatol. 2025 Oct; 93(4):1103-1106.View Related Profiles. PMID: 40490100
     
  10. Moncayo AK, Ferguson JM, Dizon MP, Huhmann L, Kim DY, Do N, Brophy MT, Osborne TF, Spence AC, Fillmore NR, Swetter SM, Hartman RI. Area Deprivation Index and Melanoma Thickness in Veterans. JAMA Dermatol. 2025 Jun 01; 161(6):582-588.View Related Profiles. PMID: 40047783; PMCID: PMC11886871; DOI: 10.1001/jamadermatol.2025.0311;
     
Showing 10 of 95 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 95 publications over 8 distinct years, with a maximum of 20 publications in 2023

YearPublications
20141
20195
20206
202112
202214
202320
202419
202518


2018 Baylor College of Medicine Center of Excellence in Health Equity, Training & Research, Houston, TX: VA Boston Healthcare System, Center of Excellence Research Summit
2016-2017 VA Boston Healthcare System: Big Data-Scientist Training Enhancement Program (BD-STEP) Fellowship
2011-2014 University of Wisconsin-Madison: Computation and Informatics in Biology and Medicine Traineeship (full support)
Contact for Mentoring:

72 E. Concord Street
Boston MA 02118
Google Map

617.638.7012
Download vCard

Fillmore's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (199) concept(s)
_
Co-Authors
See all (39) people
_
Similar People
See all (60) people
_
Same Department
Search Department